Pharmacokinetics of Flupirtine maleate in Chinese Han Nationality Healthy Volunteers
XIA Dong-ya1, GUO Tao1*, LIU Long-xing 1,2, TANG Yun-biao1, YAN Ming1
Author information+
1.Department of Pharmacy, General Hospital of Shenyang Military Region, Shenyang 110840, China; 2. Shenyang Pharmaceutical University, Shenyang 110016, China
{{custom_zuoZheDiZhi}}
{{custom_authorNodes}}
{{custom_bio.content}}
{{custom_bio.content}}
{{custom_authorNodes}}
Collapse
History+
Received
Revised
Published
2011-11-11
2011-11-11
2012-01-01
Issue Date
2011-02-05
Abstract
OBJECTIVE To investigate the pharmacokinetics of flupirtine maleate in Chinese Han nationality healthy volunteers. METHODS 10 Healthy volunteers were given with a single oral dose (100 mg of flupirtine maleate capsule. Blood samples were collected from vein at certain sampling times. Flupirtine maleate in plasma were determined by HPLC fluorescence method,and the pharmacokinetic parameters were calculated by 3P97 software. RESULTS The plasma concentration-time curves of flupirtine were discribed by a two-compartment model with first order absorption. The main pharmacokinetic parameters were as follows: tmax (1.70±0.79 h, ρmax (1 078.1±296.7 μg·L-1, t1/2α(1.46±0.51h,t1/2β(9.37±2.57h and AUC0-∞(8 971.7±1 996.5μg·h·L-1. CONCLUSION The pharmacokinetic parameters of flupirtine maleate in healthy volunteers after an oral single dose of flupirtine maleate capsule is concordant with that of the literature.
XI Dong-y;GUO To;LIU Long-xing;TNG Yun-io;YN Ming.
Pharmacokinetics of Flupirtine maleate in Chinese Han Nationality Healthy Volunteers[J]. Chinese Pharmaceutical Journal, 2011, 46(3): 218-220
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] CHEN R L, ZHAO Z G. Pharmacology and clinical evaluation of flupirtine[J]. Chin New Drugs J (中国新药杂志,2008, 17(11: 981-984 [2] CHEN X Y, ZHONG D F, XU H Y, et al. Simultaneous determination of flupirtine and its major active metabolite in human plasma by chromatography-tandem mass spectrometry[J]. J Chromatography B, 2001, 755(2:195-202. [3] FRIEDEL H A, FITTON A. Flupirtine a review of its pharmacological propertics, and therapeatic efficay in pain states[J]. Drug, 1993, 45(4: 548-569.